Giuseppe Liberatore
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Effect of Rituximab on Neurofilament Levels in CIDP: Results From the CIDPRIT Randomized Trial.
Journal: Journal of the peripheral nervous system : JPNS
Published: September 17, 2025
Splicing-based biomarkers define a robust multigene classifier for relapsing-remitting multiple sclerosis.
Journal: Journal of translational autoimmunity
Published: July 21, 2025
Rituximab versus placebo for chronic inflammatory demyelinating polyradiculoneuropathy: a randomized trial.
Journal: Brain : a journal of neurology
Published: September 02, 2024
Cytokines and chemokines in patients with chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: A systematic review.
Journal: Journal of the peripheral nervous system : JPNS
Published: December 02, 2023
Correction to: Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: November 26, 2023
Prospective open-label trial with rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy not responding to conventional immune therapies.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: October 21, 2023
Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants.
Journal: European journal of neurology
Published: August 10, 2023
Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: December 27, 2022
The circular RNA landscape in multiple sclerosis: Disease-specific associated variants and exon methylation shape circular RNA expression profile.
Journal: Multiple sclerosis and related disorders
Published: September 01, 2022
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: June 23, 2022
Comparison of the diagnostic accuracy of the 2021 EAN/PNS and 2010 EFNS/PNS diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: April 02, 2022
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy.
Journal: EBioMedicine
Published: February 23, 2022
Last Updated: 09/26/2026